Fig. 4From: Perspectives of Australian policy-makers on the potential benefits and risks of technologically enhanced communicable disease surveillance – a modified Delphi surveyPanellist’s preferences as to the conditions under which the possession of isolates collected from a commercial company should carry with it the authority to conduct a test not agreed to at the time of collection (Round 3)Back to article page